Related Experiment Video
Updated: Mar 9, 2026
03:47
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
723
TB management by private practitioners - Is it bad everywhere?
P S Rakesh1, Shibu Balakrishnan2, S Jayasankar3
1Amrita Institute of Medical Sciences and Research Center, Amrita Viswavidhyapeetham, Kerala, India.
The Indian Journal of Tuberculosis
|December 22, 2016
Summary
Private doctors in Kerala demonstrate reasonable tuberculosis (TB) prescribing practices, with most adhering to standard treatment durations and drug regimens. This suggests effective TB management can help prevent drug-resistant TB (DR TB).
Area of Science:
- Public Health
- Infectious Diseases
- Pharmacology
Background:
- Poor prescribing practices are linked to the rise of drug-resistant tuberculosis (DR TB).
- Previous studies highlighted inappropriate TB management by private practitioners in high DR TB areas.
- Kerala, with low TB transmission and DR TB, was chosen to assess private sector prescribing.
Purpose of the Study:
- To evaluate the tuberculosis (TB) prescribing practices of private sector doctors in Kerala.
- To understand if current practices align with standards for TB care in a low DR TB prevalence region.
Main Methods:
- A survey questionnaire on standard TB prescription practices was administered.
- The study targeted private practitioners managing TB who attended continuing medical education programs.
Main Results:
- 124 questionnaires were analyzed; no doctor prescribed anti-TB regimens shorter than 6 months.
- Only 5.6% prescribed incomplete intensive phase regimens (lacking H, R, Z, E).
- 82.7% of doctors prescribing private anti-TB regimens believed at least 80% of patients completed treatment.
Conclusions:
- Private sector doctors in Kerala exhibit reasonable TB management practices.
- Effective TB treatment, adhering to standards of care, is crucial for preventing DR TB emergence.
- This study supports the link between appropriate prescribing and controlling DR TB.
Related Concept Videos
01:28Pulmonary Tuberculosis V
719
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
719
01:26Pulmonary Tuberculosis IV
592
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
592
01:29Pulmonary Tuberculosis I
1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
01:31Pulmonary Tuberculosis III
1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
01:28Pulmonary Tuberculosis II
1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
01:28Pneumonia IV: Management
991
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
991